Logo

American Heart Association

  37
  0


Final ID:

Debate: Seeing the Fire or Measuring the Smoke? The Battle for Superior Risk Stratification: Inflammatory Biomarkers

  • Antoniades, Charalambos  ( UNIVERSITY OXFORD , Oxford , United Kingdom )
  • Fayad, Zahi  ( MOUNT SINAI MEDICAL CENTER , New York , New York , United States )
  • Author Disclosures:
    Charalambos Antoniades: DO have relevant financial relationships ; Individual Stocks/Stock Options:Caristo Diagnostics:Active (exists now) ; Speaker:Amarin:Past (completed) ; Speaker:Novonordisk:Expected (by end of conference) ; Consultant:UCB:Active (exists now) ; Research Funding (PI or named investigator):Sanofi:Past (completed) ; Research Funding (PI or named investigator):Astra Zeneca:Active (exists now) ; Research Funding (PI or named investigator):Lexicon:Active (exists now) ; Consultant:Caristo:Active (exists now) ; Consultant:Abcentra:Active (exists now) ; Consultant:Amgen:Past (completed) ; Researcher:Nodthera:Past (completed) ; Consultant:Novartis:Past (completed) | Zahi Fayad: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Inflammation and Atherosclerosis: Smoldering Threat or Therapeutic Target?

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts from these authors:
Elevated Lipoprotein(a) Is Independently Associated With Greater Infarct Size, Especially in Premature Atherosclerosis

Voros Szilard, Dayspring Thomas, Boatwright Wess, Brown Bradley, Lozama Tony, Watson David, Barnes Michael, Rodriguez Fatima, Mehta Anurag, Fayad Zahi

Finding Lp(a): “little” Things, Big Consequences

Wong Nathan, Donato Leslie, Fayad Zahi

You have to be authorized to contact abstract author. Please, Login
Not Available